Is biological therapy in systemic sclerosis the answer? Durga Prasanna MisraSakir AhmedVikas Agarwal Review 20 January 2020 Pages: 679 - 694
Macrophage activation syndrome in juvenile dermatomyositis: a systematic review Dimitri PoddigheKaisar Dauyey Systematic Review 16 September 2019 Pages: 695 - 702
Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease—a randomised controlled trial Nupoor AcharyaShefali Khanna SharmaSanjay Jain Clinical Trials 01 April 2020 Pages: 703 - 710
In-hospital mortality in patients with systemic lupus erythematosus: a study from Jordan 2002–2017 Marwan H. AdwanUla QasemKhader N. Mustafa Epidemiology of RMD 07 March 2020 Pages: 711 - 717
Rituximab effect in severe progressive connective tissue disease-related lung disease: preliminary data Alejandro Robles-PerezJordi DorcaJavier Narváez Observational Research 10 March 2020 Pages: 719 - 726
High interleukin-18 and low FOXP3 mRNAs in peripheral blood of women with severe systemic lupus erythematosus: a cross-sectional study Lyuba D. MitevaIrena M. ManolovaSpaska A. Stanilova Observational Research 09 March 2020 Pages: 727 - 735
Applicability of shear wave elastography for the evaluation of skin strain in systemic sclerosis Piotr SobolewskiMaria MaślińskaIrena Walecka Observational Research Open access 07 March 2020 Pages: 737 - 745
Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies Michaela KoehmMatthew J. McIntoshFrank Behrens Observational Research Open access 10 February 2020 Pages: 747 - 755
The evaluation of anxiety, depression and quality of life scores of children and adolescents with familial Mediterranean fever Arzu Önal SönmezHafize Emine SönmezNuray Aktay Ayaz Observational Research 25 January 2020 Pages: 757 - 763
Methotrexate-related toxicity in patients with rheumatoid arthritis and renal dysfunction Jung Sun LeeJi Seon OhSeokchan Hong Pharmacovigilance 13 March 2020 Pages: 765 - 770
Drug reactions in children with rheumatic diseases receiving parenteral therapies: 9 years’ experience of a tertiary pediatric rheumatology center Rahime KoçHafize Emine SönmezNuray Aktay Ayaz Pharmacovigilance 21 December 2019 Pages: 771 - 776
Systemic lupus erythematosus and hydroxychloroquine-related acute intermittent porphyria Enrique Esteve-ValverdeAlfonso Tapiz-ReulaJaume Alijotas-Reig Case Based Review 21 December 2019 Pages: 777 - 783
Glomerulonephritis and Coombs-positive hemolytic anemia mimicking scleroderma renal crisis in an overlap of systemic lupus erythematosus and diffuse systemic sclerosis Ali TaylanEmel TekinBahar Engin Case Based Review 07 November 2019 Pages: 785 - 789
Tocilizumab-induced anaphylaxis in patients with adult-onset Still’s disease and systemic juvenile idiopathic arthritis: a case-based review Eun Hye ParkEun Young LeeHyoun-Ah Kim Case Based Review 09 October 2019 Pages: 791 - 798
Pregnancy and Takayasu arteritis: case-based review Nirvana BharuthramMohammed Tikly Case Based Review 19 December 2019 Pages: 799 - 809
Acute pancreatitis and macrophage activation syndrome in pediatric systemic lupus erythematosus: case-based review Qiang LinMan ZhangXiaozhong Li Cases with a Message Open access 03 August 2019 Pages: 811 - 819
Arthralgia as an initial presentation of COVID-19: observation Beuy JoobViroj Wiwanitkit Correspondence 28 March 2020 Pages: 823 - 823
Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs Tsvetoslav Georgiev Correspondence 30 March 2020 Pages: 825 - 826
COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence Vincenzo VeneritoGiuseppe LopalcoFlorenzo Iannone Correspondence 30 March 2020 Pages: 827 - 828
